Drawing for CIRECA THERANOSTICS

USPTO serial 85982315

CIRECA THERANOSTICS

Reviewed by CopyMark Law Group

Reg. 4679528Status 710
Filing date
Status date
Registration date
Jan 27, 2015
Examiner
KOLACZ, KATHLEEN L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CIRECA THERANOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Zinna

MICHAEL J. ZINNA WARD & ZINNA, LLC382 SPRINGFIELD AVE STE 300SUMMIT, NJ 07901-2707UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Cloud computing for pathology and whole slide imaging featuring software for use in automated acquisition and analysis of images of human and animal cells and tissues, for use in entering, storing and analyzing data, for management of medical diagnostic, prognostic and predictive information by clinicians, research scientists and pathologists and other laboratory professionals in the fields of pathology, oncology, pharmaceutical drug and therapy development and whole slide imaging, data reporting, tissue bank sample management and test results archiving, with data archiving and retrieval features; providing databases in the field of spectral imaging information based on biomarkers for disease detection and treatment for scientific research purposes; providing an on-line searchable database in the field of pathology and the use of biomarkers for disease detection and treatment for scientific research purposes only; clinical laboratory providing biomarker research services; data mining of database featuring patient sample biomarkers; biomarker screening for scientific research purposes; pharmaceutical drug design; pharmaceutical research and development services in the fields of drug design and drug delivery; conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical research and development in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; and companion diagnostics and assays services in the field of gene therapy design and delivery; and laboratory services, namely, archiving tissue and cell samples for use in the field of gene therapy design and delivery for research purposesSECTION 8 - CANCELLEDOct 24, 2013
044Providing on-line searchable databases featuring health-related information on spectral results of biomarkers used in the detection and treatment of disease; medical diagnostic reporting, prognostic and predictive reporting; medical services in the fields of cytology, histology and pathology; medical adjunctive and triage testing for diagnostic or treatment purposes; medical prognostic and diagnostic testing in the field of biomarkers for disease detection and treatment; medical screening, monitoring, companion diagnostic testing services; medical services, namely, gene therapy design and delivery services in the fields of oncology, pathology, and biomarkersSECTION 8 - CANCELLEDOct 24, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2021C8..CANCELLED SEC. 8 (6-YR)—
Jul 5, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 27, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 23, 2014SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED—
Dec 21, 2014CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 10, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 9, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 9, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 4, 2014CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2014CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2014MPMKNOTICE OF PSEUDO MARK MAILED—
Aug 13, 2014SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 13, 2014DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 12, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 14, 2014IUAFUSE AMENDMENT FILED—
Jul 14, 2014DRRRDIVISIONAL REQUEST RECEIVED—
Jul 14, 2014ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jul 14, 2014EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 14, 2014NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 19, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 30, 2013NPUBNOTICE OF PUBLICATION—
Oct 15, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 7, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 13, 2013CNEAEXAMINERS AMENDMENT MAILED—
Sep 13, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Sep 13, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 26, 2013CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2013CNEAEXAMINERS AMENDMENT MAILED—
Jun 20, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Jun 20, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 31, 2012CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 29, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 16, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 16, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 2012ALIEASSIGNED TO LIE—
Aug 3, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2012CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2012DOCKASSIGNED TO EXAMINER—
Feb 14, 2012MPMKNOTICE OF PSEUDO MARK MAILED—
Feb 13, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 11, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance